Clinical Trial Update: CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating CBD for pain reduction and opioid use after ankle and tibia fracture ORIF was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankle Fracture
• Tibia Fracture

Drugs mentioned

• CBD (cannabidiol)

Snippet

Sponsor: NYU Langone Health | Conditions: Ankle Fractures, Tibia Fracture | Phase 4 | Status: WITHDRAWN